We are studying an investigational drug, denifanstat, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with noncirrhotic NASH (non-alcoholic steatohepatitis) MASH (metabolic dysfunction-associated steatohepatitis).
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
A Barritt
Center for Gastrointestinal Biology and Disease
Clinical or Medical
Interventional
Kidneys and Liver
24-2226
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
